Trevo ProVue Retriever Allows Physicians to Visualize Placement, Clot Interaction and Retrieval

The world's first fully visible stent retriever device to treat acute ischemic stroke expands Stryker's commitment to complete stroke care


November 19, 2012

The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device.

The Trevo ProVue Retriever is supported by robust clinical evidence from the Trevo family of Retrievers in the TREVO and TREVO 2 clinical trials, which demonstrated high revascularization and improved clinical outcomes compared to the first generation Merci Retriever. The device has been granted 510(k) market clearance by the U.S. Food and Drug Administration (FDA) and is also available in international markets where it has been cleared for sale.

For more information: